JAK-1 Inhibitor Effective for RA, but Safety Signal Troubles JAK-1 Inhibitor Effective for RA, but Safety Signal Troubles

The oral JAK-1 inhibitor upadacitinib is showing a strong response in active rheumatoid arthritis that has responded inadequately to biologics; however, concern lingers about venous thrombotic events.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news